Obesity and head and neck cancer risk and survival by human papillomavirus serology

被引:20
作者
Tan, Xinmiao [1 ]
Nelson, Heather H. [2 ,3 ]
Langevin, Scott M. [4 ]
McClean, Michael [5 ]
Marsit, Carmen J. [6 ]
Waterboer, Tim [7 ]
Pawlita, Michael [7 ]
Kelsey, Karl T. [1 ,8 ]
Michaud, Dominique S. [1 ,9 ]
机构
[1] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA
[2] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[3] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA
[4] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA
[5] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA
[6] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH USA
[7] German Canc Res Ctr, DKFZ, Res Program Infect & Canc, Heidelberg, Germany
[8] Brown Univ, Sch Med, Dept Pathol & Lab Med, Providence, RI 02912 USA
[9] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England
关键词
Head and neck cancer; Obesity; HPV serology; BODY-MASS INDEX; SQUAMOUS-CELL CARCINOMA; OROPHARYNGEAL CANCER; ORAL-CAVITY; ALCOHOL; ASSOCIATION; SMOKING; EPIDEMIOLOGY; METAANALYSIS; MORTALITY;
D O I
10.1007/s10552-014-0490-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies examining the association of body mass index (BMI) with risk of and survival from head and neck squamous cell carcinoma (HNSCC) have been inconsistent, although an inverse association has been noted for obesity and risk of HNSCC in several studies. Previous studies have not examined whether these associations differ by human papillomavirus (HPV) status. We utilized the resources of a population-based case-control study of HNSCC from the greater Boston area (959 cases and 1,208 controls were eligible for this analysis). Anthropometric history was collected through personal interviews, and HPV status was assessed using serology. We analyzed the association between BMI (assessed 5 years prior to disease incidence) and disease risk and survival using logistic regression and Cox proportional hazards regression, respectively. After adjusting for known risk factors, the association between obesity and overall risk of HNSCC was not significant (OR 0.79, 95 % CI 0.60-1.04). However, obesity (BMI a parts per thousand yen30 kg/m(2)) was inversely associated with HNSCC risk among HPV-seronegative cases (OR 0.48, 95 % CI 0.32-0.70), but not among HPV-seropositive cases (OR 0.91, 95 % CI 0.68-1.21). BMI was not associated with survival overall or by HPV status. However, being overweight (BMI 25-29.9 kg/m(2)) was associated with longer survival among HPV-seropositive smokers (HR 0.48, 95 % CI 0.31-0.74). Our findings are consistent with previous observations that obesity is inversely associated with the risk of HNSCC; however, this association appears to be confined to HPV-seronegative cases. Overall, obesity was not associated with HNSCC survival overall or by HPV status. Obesity is associated with risk of non-HPV HNSCC, but not HPV HNSCC.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [41] Depression and survival in head and neck cancer patients
    Rieke, Katherine
    Schmid, Kendra K.
    Lydiatt, William
    Houfek, Julia
    Boilesen, Eugene
    Watanabe-Galloway, Shinobu
    ORAL ONCOLOGY, 2017, 65 : 76 - 82
  • [42] Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status
    Habbous, Steven
    Harland, Luke T. G.
    La Delfa, Anthony
    Fadhel, Ehab
    Xu, Wei
    Liu, Fei-Fei
    Goldstein, David
    Waldron, John
    Huang, Shao-Hui
    O'Sullivan, Brian
    Liu, Geoffrey
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (06): : 802 - 810
  • [43] Human papillomavirus and cancerous diseases of the head and neck: a systematic review and meta-analysis
    Saulle, R.
    Semyonov, L.
    Mannocci, A.
    Careri, A.
    Saburri, F.
    Ottolenghi, L.
    Guerra, F.
    La Torre, G.
    ORAL DISEASES, 2015, 21 (04) : 417 - 431
  • [44] Prevalence of Human Papillomavirus (HPV) Infection and the Association with Survival in Saudi Patients with Head and Neck Squamous Cell Carcinoma
    Alsbeih, Ghazi
    Al-Harbi, Najla
    Bin Judia, Sara
    Al-Qahtani, Wejdan
    Khoja, Hatim
    El-Sebaie, Medhat
    Tulbah, Asma
    CANCERS, 2019, 11 (06):
  • [45] Human papillomavirus, smoking, and head and neck cancer
    Sinha, Parul
    Logan, Henrietta L.
    Mendenhall, William M.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (01) : 130 - 136
  • [46] Increase in head and neck cancer in younger patients due to human papillomavirus (HPV)
    Young, David
    Xiao, Christopher C.
    Murphy, Benjamin
    Moore, Michael
    Fakhry, Carole
    Day, Terry A.
    ORAL ONCOLOGY, 2015, 51 (08) : 727 - 730
  • [47] Clinical and scientific impact of human papillomavirus on head and neck cancer
    Friedman, Jeffrey M.
    Stavas, Mark J.
    Cmelak, Anthony J.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 781 - 791
  • [48] Human Papillomavirus Status in Head and Neck Cancer The Ethics of Disclosure
    Shuman, Andrew G.
    Wolf, Gregory T.
    CANCER, 2010, 116 (18) : 4221 - 4226
  • [49] Management of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Cancer
    Mehra, Ranee
    Ang, K. Kian
    Burtness, Barbara
    SEMINARS IN RADIATION ONCOLOGY, 2012, 22 (03) : 194 - 197
  • [50] Risk Prediction Models for Head and Neck Cancer in the US Population From the INHANCE Consortium
    Lee, Yuan-Chin Amy
    Al-Temimi, Mohammed
    Ying, Jian
    Muscat, Joshua
    Olshan, Andrew F.
    Zevallos, Jose P.
    Winn, Deborah M.
    Li, Guojun
    Sturgis, Erich M.
    Morgenstern, Hal
    Zhang, Zuo-Feng
    Smith, Elaine
    Kelsey, Karl
    McClean, Michael
    Vaughan, Thomas L.
    Lazarus, Philip
    Chen, Chu
    Schwartz, Stephen M.
    Gillison, Maura
    Schantz, Stimson
    Yu, Guo-Pei
    D'Souza, Gypsyamber
    Gross, Neil
    Monroe, Marcus
    Kim, Jaewhan
    Boffetta, Paolo
    Hashibe, Mia
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2020, 189 (04) : 330 - 342